These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15897971)

  • 41. MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells.
    Park JS; Park JH; Khoi PN; Joo YE; Jung YD
    Carcinogenesis; 2011 Feb; 32(2):175-81. PubMed ID: 21081472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Involvement of MAPK pathway in hypoxia-induced up-regulation of urokinase plasminogen activator receptor in a human prostatic cancer cell line, PC3MLN4.
    Lee KH; Choi EY; Hyun MS; Kim JR
    Exp Mol Med; 2004 Feb; 36(1):57-64. PubMed ID: 15031672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fucoxanthin induces GADD45A expression and G1 arrest with SAPK/JNK activation in LNCap human prostate cancer cells.
    Satomi Y
    Anticancer Res; 2012 Mar; 32(3):807-13. PubMed ID: 22399598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NFkappaB-dependent regulation of urokinase plasminogen activator by proanthocyanidin-rich grape seed extract: effect on invasion by prostate cancer cells.
    Uchino R; Madhyastha R; Madhyastha H; Dhungana S; Nakajima Y; Omura S; Maruyama M
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):528-33. PubMed ID: 20502321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells.
    Ide H; Nakagawa T; Terado Y; Kamiyama Y; Muto S; Horie S
    Biochem Biophys Res Commun; 2008 May; 369(2):292-6. PubMed ID: 17920038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription.
    Benasciutti E; Pagès G; Kenzior O; Folk W; Blasi F; Crippa MP
    Blood; 2004 Jul; 104(1):256-62. PubMed ID: 15031204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling.
    Jo M; Thomas KS; Wu L; Gonias SL
    J Biol Chem; 2003 Nov; 278(47):46692-8. PubMed ID: 12963722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.
    Ahmed N; Pansino F; Baker M; Rice G; Quinn M
    J Cell Biochem; 2002; 84(4):675-86. PubMed ID: 11835393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines.
    Hasanuzzaman M; Kutner R; Agha-Mohammadi S; Reiser J; Sehgal I
    Mol Cancer; 2007 May; 6():34. PubMed ID: 17509140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The superoxide scavenger TEMPOL induces urokinase receptor (uPAR) expression in human prostate cancer cells.
    Lejeune D; Hasanuzzaman M; Pitcock A; Francis J; Sehgal I
    Mol Cancer; 2006 Jun; 5():21. PubMed ID: 16756681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.
    Thomas S; Chiriva-Internati M; Shah GV
    Clin Exp Metastasis; 2007; 24(5):363-77. PubMed ID: 17487556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Androgen induction of urokinase gene expression in LNCaP cells is dependent on their interaction with the extracellular matrix.
    Pentyala SN; Whyard TC; Waltzer WC; Meek AG; Hod Y
    Cancer Lett; 1998 Aug; 130(1-2):121-6. PubMed ID: 9751264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.
    Li W; Wu CL; Febbo PG; Olumi AF
    Am J Pathol; 2007 Oct; 171(4):1189-98. PubMed ID: 17702894
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Membrane initiated signaling by 1,25alpha-dihydroxyvitamin D3 in LNCaP prostate cancer cells.
    Larsson D; Hagberg M; Malek N; Kjellberg C; Senneberg E; Tahmasebifar N; Johansson V
    Adv Exp Med Biol; 2008; 617():573-9. PubMed ID: 18497084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo.
    Rabbani SA; Ateeq B; Arakelian A; Valentino ML; Shaw DE; Dauffenbach LM; Kerfoot CA; Mazar AP
    Neoplasia; 2010 Oct; 12(10):778-88. PubMed ID: 20927316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calcitonin stimulates the secretion of urokinase-type plasminogen activator from prostate cancer cells: its possible implications on tumor cell invasion.
    Sabbisetti V; Chigurupati S; Thomas S; Shah G
    Int J Cancer; 2006 Jun; 118(11):2694-702. PubMed ID: 16381004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells.
    Castilla C; Flores ML; Conde JM; Medina R; Torrubia FJ; Japón MA; Sáez C
    Clin Exp Metastasis; 2012 Apr; 29(4):349-58. PubMed ID: 22274591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer.
    Pulukuri SM; Estes N; Patel J; Rao JS
    Cancer Res; 2007 Feb; 67(3):930-9. PubMed ID: 17283123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype.
    Aguirre Ghiso JA; Alonso DF; Farías EF; Gomez DE; de Kier Joffè EB
    Eur J Biochem; 1999 Jul; 263(2):295-304. PubMed ID: 10406935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Snail mediates invasion through uPA/uPAR and the MAPK signaling pathway in prostate cancer cells.
    Randle DD; Clarke S; Henderson V; Odero-Marah VA
    Oncol Lett; 2013 Dec; 6(6):1767-1773. PubMed ID: 26889270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.